Empowering Cardiologists with Precision. Transforming Cardiac Care—One Innovation at a Time.
Ludhiana( Punjabiheadline Harminder singh kitty)RELISYS Medical Devices is proud to announce the addition of two cutting-edge innovations to its growing portfolio for the treatment of Complex Coronary Artery Disease (CAD) — the Pearl CB (Coronary Cutting Balloon) and Pearl DCB (Paclitaxel Drug-Coated Balloon).
These advanced devices are engineered with precision and developed to empower interventional cardiologists in performing complex coronary procedures with greater safety, accuracy, and clinical outcomes.
✨ Pearl CB – Coronary Cutting Balloon:
Designed for controlled plaque modification and optimal luminal gain, Pearl CB offers superior deliverability and cutting efficiency in complex, calcified lesions.
✨ Pearl DCB – Paclitaxel Drug-Coated Balloon:
Built on a proven drug delivery platform, Pearl DCB ensures effective antiproliferative drug transfer, reducing restenosis and supporting long-term vessel patency—without leaving a permanent implant behind.
Speaking on the launch, a RELISYS spokesperson said,
> “Our mission has always been to equip healthcare professionals with world-class tools that advance patient outcomes. The Pearl CB and Pearl DCB represent our continued commitment to innovation, quality, and excellence in cardiac intervention.”
With these additions, RELISYS strengthens its position as a leading Indian manufacturer of high-quality interventional devices that meet global standards of performance and safety.
Together with healthcare professionals, RELISYS continues its mission to transform cardiac care—cutting through complexity and delivering innovation straight to the heart.
“Precision. Performance. Progress — RELISYS leading the future of coronary care.”
